Trial in Progress: A Phase 1 Umbrella Study of TCR-Engineered T Cells That Target HA-1 (TSC-100) and HA-2 (TSC-101) to Treat Residual Leukemia after Hematopoietic Cell Transplantation
| العنوان: | Trial in Progress: A Phase 1 Umbrella Study of TCR-Engineered T Cells That Target HA-1 (TSC-100) and HA-2 (TSC-101) to Treat Residual Leukemia after Hematopoietic Cell Transplantation |
|---|---|
| المؤلفون: | Ran Reshef, Hyung C. Suh, Monzr M. Al Malki, Aasiya Matin, Ashish S Kothari, Allison Bell, Antoine J Boudot, Yun Wang, Nina Abelowitz, James Murray, Gavin Macbeath, Debora Barton, Shrikanta Chattopadhyay |
| المصدر: | Blood. 140:7468-7469 |
| بيانات النشر: | American Society of Hematology, 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | Immunology, Cell Biology, Hematology, Biochemistry |
| تدمد: | 1528-0020 0006-4971 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::26d9645fff4f38b169dd9fbf10c7b541 https://doi.org/10.1182/blood-2022-167707 |
| رقم الأكسشن: | edsair.doi...........26d9645fff4f38b169dd9fbf10c7b541 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15280020 00064971 |
|---|